167
Views
6
CrossRef citations to date
0
Altmetric
Original Articles

Kidney cancer in Sweden: A decrease in incidence and tumour stage, 1979 – 2001

, , , &
Pages 302-310 | Received 09 Apr 2012, Accepted 12 Sep 2012, Published online: 09 Nov 2012

References

  • Jayson M, Sanders H. Increased incidence of serendipitously discovered renal cell carcinoma. Urology 1998;51:203–5.
  • Sanchez-Martin FM, Millan-Rodriguez F, Urdaneta-Pignalosa G, Rubio-Briones J, Villavicencio-Mavrich H. Small renal masses: incidental diagnosis, clinical symptoms, and prognostic factors. Adv Urol 2008;2008:310694.
  • Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin 2009;59:225–49.
  • Mathew A, Devesa SS, Fraumeni JF Jr, Chow WH. Global increases in kidney cancer incidence, 1973–1992. Eur J Cancer Prev 2002;11:171–8.
  • Lindblad P. Epidemiology of renal cell carcinoma. Scand J Surg 2004;93:88–96.
  • Chow WH, Dong LM, Devesa SS. Epidemiology and risk factors for kidney cancer. Nat Rev Urol 2010;7:245–57.
  • Engholm G, Hakulinen T, Gislum M, Tryggvadottir L, Klint A, Bray F, Trends in the survival of patients diagnosed with kidney or urinary bladder cancer in the Nordic countries 1964–2003 followed up to the end of 2006. Acta Oncol 2010;49:655–64.
  • Kovacs G, Akhtar M, Beckwith BJ, Bugert P, Cooper CS, Delahunt B, The Heidelberg classification of renal cell tumours. J Pathol 1997;183:131–3.
  • Fuhrman SA, Lasky LC, Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 1982;6:655–63.
  • Storkel S, Eble JN, Adlakha K, Amin M, Blute ML, Bostwick DG, Classification of renal cell carcinoma: Workgroup No. 1. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC). Cancer 1997;80:987–9.
  • Reuter VE, Presti JC Jr. Contemporary approach to the classification of renal epithelial tumors. Semin Oncol 2000;27:124–37.
  • Medeiros LJ, Jones EC, Aizawa S, Aldape HC, Cheville JC, Goldstein NS, Grading of renal cell carcinoma: Workgroup No. 2. Union Internationale Contre le Cancer and the American Joint Committee on Cancer (AJCC). Cancer 1997;80:990–1.
  • McLaughlin JK, Chow WH, Mandel JS, Mellemgaard A, McCredie M, Lindblad P, International renal-cell cancer study. VIII. Role of diuretics, other anti-hypertensive medications and hypertension. Int J Cancer 1995;63:216–21.
  • McLaughlin JK, Lindblad P, Mellemgaard A, McCredie M, Mandel JS, Schlehofer B, International renal-cell cancer study. I. Tobacco use. Int J Cancer 1995;60:194–8.
  • Rosenberg L, Rao RS, Palmer JR, Strom BL, Zauber A, Warshauer ME, Transitional cell cancer of the urinary tract and renal cell cancer in relation to acetaminophen use (United States). Cancer Causes Control 1998;9:83–8.
  • Adami HO, McLaughlin JK, Hsing AW, Wolk A, Ekbom A, Holmberg L, Alcoholism and cancer risk: a population-based cohort study. Cancer Causes Control 1992;3:419–25.
  • Sali D, Boffetta P. Kidney cancer and occupational exposure to asbestos: a meta-analysis of occupational cohort studies. Cancer Causes Control 2000;11:37–47.
  • Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74–108.
  • Statistics Sweden SCB. Health and medical care. The National Board of Health and Welfare. SCB2004; Stockholm: SCB.www.socialstyrelsen.se/folkhalsa
  • Neovius M, Janson A, Rössner S. Prevalence of obesity in Sweden. Obes Rev 2006;1–1–3.
  • National Board of Health and Welfare. Socialstyrelsen. Dödsorsaker 2007. Causes of death 2007. National Report 2009.www.socialstyrelsen.se/register/dodsorsaksregister
  • Hellsten S, Berge T, Wehlin L. Unrecognized renal cell carcinoma, clinical and pathological aspects. Scand J Urol Nephrol 1981;15:273–8.
  • Mindrup SR, Pierre JS, Dahmoush L, Konety BR. The prevalence of renal cell carcinoma diagnosed at autopsy. BJU Int 2005;95:31–3.
  • Onkologiskt Centrum ocks. Swedish Cancer Register, report 2005–2010. Nationellt kvalitetsregister 2005–2010;1:1–29.
  • Sunela KL, Kataja MJ, Kellokumpu-Lehtinen PL. Changes in symptoms of renal cell carcinoma over four decades. BJU Int 2010;106:649–53.
  • Beisland C, Medby PC, Beisland HO. Renal cell carcinoma: gender difference in incidental detection and cancer-specific survival. Scand J Urol Nephrol 2002;36:414–18.
  • Lyrdal D, Stierner U, Lundstam S. Metastatic renal cell carcinoma treated with Peg-interferon alfa-2b. Acta Oncol 2009;48:901–8.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.